Literature DB >> 20518484

Membrane association facilitates degradation and cleavage of the cyclin-dependent kinase 5 activators p35 and p39.

Seiji Minegishi1, Akiko Asada, Shinya Miyauchi, Takahiro Fuchigami, Taro Saito, Shin-Ichi Hisanaga.   

Abstract

Cyclin-dependent kinase 5 (Cdk5) is activated by binding to its activators, p35 and p39. The level of Cdk5 activity is determined by the amount of p35 and p39, which is regulated not only by transcription but also via proteasomal degradation. Alternatively, calpain-induced cleavage of p35 to p25 can induce aberrant Cdk5 activation. As the regulation of p35 and p39 proteolysis is not well understood, we have studied here the mechanisms governing their degradation and cleavage. We find that p35 and p39 undergo proteasomal degradation in neurons, with p39 showing a slower degradation rate than p35. Degradation of the activators is dependent on their respective N-terminal p10 region, as indicated by experiments in which cognate p10 regions were swapped between p35 and p39. The effect of the p10 region on degradation and cleavage could be assigned to its membrane binding properties, mediated predominantly by myristoylation. Together, these results indicate that both proteasomal degradation and calpain cleavage of p35 and p39 are stimulated by membrane association, which is in turn mediated via myristoylation of their p10 regions. However, p35 and p39 show differences in degradation and cleavage rates, which may in fact underlie the distinct physiological and pathological functions of these two Cdk5 activators.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20518484     DOI: 10.1021/bi100631f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  26 in total

Review 1.  Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration and Neuroprotection.

Authors:  Linda Nguyen; Brandon P Lucke-Wold; Shona Mookerjee; Nidhi Kaushal; Rae R Matsumoto
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

2.  Selenoprotein K regulation of palmitoylation and calpain cleavage of ASAP2 is required for efficient FcγR-mediated phagocytosis.

Authors:  Robert L Norton; Gregory J Fredericks; Zhi Huang; Jeffrey D Fay; FuKun W Hoffmann; Peter R Hoffmann
Journal:  J Leukoc Biol       Date:  2016-09-06       Impact factor: 4.962

3.  Characterization of the CDK5 gene in Apis cerana cerana (AccCDK5) and a preliminary identification of its activator gene, AccCDK5r1.

Authors:  Guangdong Zhao; Chen Wang; Hongfang Wang; Lijun Gao; Zhenguo Liu; Baohua Xu; Xingqi Guo
Journal:  Cell Stress Chaperones       Date:  2017-07-03       Impact factor: 3.667

Review 4.  Amyloid beta modulators and neuroprotection in Alzheimer's disease: a critical appraisal.

Authors:  Chandra Sekhar Kuruva; P Hemachandra Reddy
Journal:  Drug Discov Today       Date:  2016-10-27       Impact factor: 7.851

5.  Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid.

Authors:  Shang-Yi A Tsai; Michael J Pokrass; Neal R Klauer; Hiroshi Nohara; Tsung-Ping Su
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-11       Impact factor: 11.205

6.  S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide.

Authors:  Jing Qu; Tomohiro Nakamura; Gang Cao; Emily A Holland; Scott R McKercher; Stuart A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

Review 7.  The Role of Cdk5 in Alzheimer's Disease.

Authors:  Shu-Lei Liu; Chong Wang; Teng Jiang; Lan Tan; Ang Xing; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2015-07-31       Impact factor: 5.590

8.  Phosphorylation of cyclin-dependent kinase 5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5.

Authors:  Hiroyuki Kobayashi; Taro Saito; Ko Sato; Kotaro Furusawa; Tomohisa Hosokawa; Koji Tsutsumi; Akiko Asada; Shinji Kamada; Toshio Ohshima; Shin-ichi Hisanaga
Journal:  J Biol Chem       Date:  2014-05-28       Impact factor: 5.157

Review 9.  Cdk5 activity in the brain - multiple paths of regulation.

Authors:  Kavita Shah; Debomoy K Lahiri
Journal:  J Cell Sci       Date:  2014-06-01       Impact factor: 5.285

10.  Two Degradation Pathways of the p35 Cdk5 (Cyclin-dependent Kinase) Activation Subunit, Dependent and Independent of Ubiquitination.

Authors:  Toshiyuki Takasugi; Seiji Minegishi; Akiko Asada; Taro Saito; Hiroyuki Kawahara; Shin-ichi Hisanaga
Journal:  J Biol Chem       Date:  2015-12-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.